Núria Climent
AIDS research unit · IDIBAPS/Hospital Clínic i Provincial de Barcelona
https://researchid.co/ncliment
@clinic.cat
69Scopus Publications
Research Interests
T cell responses, dendritic cells, vaccines, HIV-1
Recent Scopus Publications
- Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial
- Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial (Nature Communications, (2026), 17, 1, (2022), 10.1038/s41467-026-69846-7)
- Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells
- Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trial
- Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression
Links
- ORCID https://orcid.org/0000-0002-0791-656X
- Scopus https://www.scopus.com/authid/detail.uri?authorId=57200906191